fbpx

Infographic: Nonsurgically Reshape Your Nose With Liquid Rhinoplasty

When it comes to reshaping and refining your nose, traditional rhinoplasty isn’t the only option. Thanks to the power of injectables like dermal fillers, our Baton Rouge patients can transform their faces with liquid rhinoplasty. This popular procedure can adjust the appearance of the nose without the need for people to “go under the knife.” It is an excellent option for those who aren’t ready to commit to surgery or who simply prefer a less-invasive treatment option.

Allergan (the maker of Juvéderm®) has named Weiler Plastic Surgery among the Top 20 aesthetic practices nationwide, so you can trust our experts to help you create a beautiful, flattering new look. Read our infographic below to learn about some of the improvements you can enjoy with liquid rhinoplasty.

Infographic: Liquid Rhinoplasty
Infographic: Nonsurgical Rhinoplasty

If you are in the Greater Baton Rouge area and interested in treatment, request a consultation online or call (225) 399-0001.

2 Responses to Infographic: Nonsurgically Reshape Your Nose With Liquid Rhinoplasty

  • RHIAN BROWN says:

    Hi I have been a patient in the past with you guys but I’ve been out of the loop for over a year dealing with a few personal tragedies so I’m looking like a train wreck. I am interested in either something like Morpheus 8 for the face or possibly threads. I’m hoping y’all can tell me what will work best. I also need Botox, Voluma, and Juvaderm (wrinkles, cheeks, lips) ASAP. I’d love to do that in next day or two. Thanks so much.
    225-828-0820

    • Shared Account says:

      Hi! Please call our office at 225.399.0001 at your earliest convivence and we would love to schedule your appointment! Have a great day!

Leave a Reply

Fields marked with * are required.

Book Now Contact

Are you struggling with your weight and ready to make some changes? This is the virtual event for you! Join our friends over at Rejuvime for their Medical Weight Loss Program Virtual Event where they will be highlighting Semaglutide and Tirzepatide.